Previous close | 72.52 |
Open | 72.51 |
Bid | 74.32 x 200 |
Ask | 74.38 x 200 |
Day's range | 71.25 - 74.55 |
52-week range | 53.79 - 94.86 |
Volume | |
Avg. volume | 950,906 |
Market cap | 10.803B |
Beta (5Y monthly) | 1.18 |
PE ratio (TTM) | 27.23 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 0.20 (0.28%) |
Ex-dividend date | 29 Feb 2024 |
1y target est | N/A |
BILLERICA, Mass., May 07, 2024--Bruker Corporation (Nasdaq: BRKR) today announced that the German Federal Patent Court has ruled in favor of NanoString Technologies Germany GmbH by invalidating European Patent No. 2794928B1 (the "928 Patent") in Germany (case 3 Ni 20/22). NanoString is now a Bruker business following Bruker’s asset acquisition of the businesses of NanoString Technologies, Inc on May 6th, 2024. The 928 Patent has been asserted by 10x Genomics against NanoString in patent infringe
BILLERICA, Mass., May 06, 2024--Bruker Corporation (Nasdaq: BRKR) today announced that it has closed its asset acquisition of the business of NanoString Technologies, Inc., headquartered in Seattle, Washington, a leading provider of life-science research solutions for spatial transcriptomics and gene expression analysis.
BILLERICA, Mass., May 02, 2024--Bruker Corporation (Nasdaq: BRKR) today announced financial results for its first quarter ended March 31, 2024.